-
Mashup Score: 19From Bench to Podcast: He, Jin and Shi | Forum - 12 hour(s) ago
Nature Biotechnology’s Forum podcast explores biotech’s latest scientific publications, found in Nature Biotechnology and elsewhere, through discussions with today’s leading researchers.
Source: shows.acast.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 7
In the journal Nature Biotechnology, scientists at Ludwig Cancer Research reported the development of an AI model to identify the most effective immune cells for cancer immunotherapy.
Source: www.azorobotics.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 98
Nature Biotechnology – EpiTrace infers cell mitotic age and evolution from single-cell ATAC-seq data.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 12Ludwig Cancer Research - 3 day(s) ago
MAY 7, 2024, NEW YORK – Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies. Combined with additional algorithms, the predictive model, described in the current issue of the journal Nature Biotechnology, can be applied to personalized cancer treatments that tailor therapy to the unique cellular makeup of each patient’s tumors. “The implementation of artificia
Source: www.ludwigcancerresearch.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 295Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms - 4 day(s) ago
Nature Biotechnology – Tumor-reactive T cell receptors are predicted based on single-cell RNA sequencing and single-cell T cell receptor sequencing.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 151Decrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics - 4 day(s) ago
Nature Biotechnology – Proteome-wide measurements of dose–response curves for 144 drugs reveal drug mechanisms of action.
Source: www.nature.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 6
Anticoagulant treatments are crucial for managing many conditions, such as heart disease, stroke and venous thrombosis. Current options, however, carry an
Source: sepoy.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 8Denmark's SNIPR Biome secures $5.48M funding from CARB-X for clinical trial of CRISPR therapy in cancer patients - ArcticStartup - 5 day(s) ago
SNIPR Biome, a Copanhagen-based clinical-stage biotech company pioneering precision medicines using CRISPR technology for microbial gene therapy, has secured
Source: arcticstartup.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 19From Bench to Podcast: He, Jin and Shi | Forum - 8 day(s) ago
Nature Biotechnology’s Forum podcast explores biotech’s latest scientific publications, found in Nature Biotechnology and elsewhere, through discussions with today’s leading researchers.
Source: shows.acast.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 4
Des scientifiques de l’Université de Genève (UNIGE), en collaboration avec des collègues en Australie, ont mis au point un nouveau type d’anticoagulant dont l’action peut être rapidement stoppée. Cela pourrait réduire considérablement le risque de saignements graves.
Source: www.rts.chCategories: General Medicine News, Future of MedicineTweet
🎙️Episode 2 of 'From Bench to Podcast' has dropped! Listen as @claudiasjv7 talks with co-authors @SiyuHe7, @YinuoJin6 & @shi_lingting about Starfysh, a computational toolbox combining spatial transcriptomics and histology data https://t.co/wPcYzRvNj2 https://t.co/6MFmFs5Zsy